Fusion Antibodies (LSE:FAB) Days Payable : 148.48 (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Fusion Antibodies Days Payable?

Fusion Antibodies's average Accounts Payable for the six months ended in Sep. 2023 was £0.51 Mil. Fusion Antibodies's Cost of Goods Sold for the six months ended in Sep. 2023 was £0.63 Mil. Hence, Fusion Antibodies's Days Payable for the six months ended in Sep. 2023 was 148.48.

The historical rank and industry rank for Fusion Antibodies's Days Payable or its related term are showing as below:

LSE:FAB' s Days Payable Range Over the Past 10 Years
Min: 63.36 Med: 74.19 Max: 148.78
Current: 148.78

During the past 9 years, Fusion Antibodies's highest Days Payable was 148.78. The lowest was 63.36. And the median was 74.19.

LSE:FAB's Days Payable is ranked worse than
50.28% of 718 companies
in the Biotechnology industry
Industry Median: 152.29 vs LSE:FAB: 148.78

Fusion Antibodies's Days Payable increased from Sep. 2022 (110.65) to Sep. 2023 (148.48). It may suggest that Fusion Antibodies delayed paying its suppliers.

Fusion Antibodies Days Payable Historical Data

The historical data trend for Fusion Antibodies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Antibodies Days Payable Chart

Fusion Antibodies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Payable

Get a 7-Day Free Trial

98.40

75.39

64.70

63.36

74.19

Fusion Antibodies Semi-Annual Data
	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Days Payable	Get a 7-Day Free Trial											95.52	118.55	110.65	130.95	148.48

Competitive Comparison of Fusion Antibodies's Days Payable

For the Biotechnology subindustry, Fusion Antibodies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Antibodies's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fusion Antibodies's Days Payable distribution charts can be found below:

* The bar in red indicates where Fusion Antibodies's Days Payable falls into.

Fusion Antibodies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Fusion Antibodies's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0.466	+	0.48)	/	2 )	/	2.327	*	365
=	0.473					/	2.327	*	365
=	74.19

Fusion Antibodies's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (0.48	+	0.537)	/	2 )	/	0.625	*	365 / 2
=	0.5085					/	0.625	*	365 / 2
=	148.48

Fusion Antibodies Days Payable Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Antibodies (LSE:FAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fusion Antibodies PLC (LSE:FAB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL

Website

https://www.fusionantibodies.com

Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Fusion Antibodies (LSE:FAB) Headlines

From GuruFocus

626 Financial, LLC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor • 10-21-2022